ClinicalTrials.gg
Drug

Tesamorelin clinical trials

Also written Egrifta and TH9507.

studies test it
18
open now
3
in phase 3
2
first study started
2002

How each study uses tesamorelin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tesamorelin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Nov 2010 · Egrifta · BLA 022505 (FDA, Purple Book)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tesamorelin
13

Brand

Egrifta
6

Development codes

TH9507
3

Studies by the year they started

18 studies that test it; most in 2008 (2)

Studies that test tesamorelin, by start year
YearStudies
20021
20051
20061
20071
20082
20101
20111
20121
20141
20151
20161
20171
20182
20191
20251
20261

Who runs them

Industry 7 · Other 11

Massachusetts General Hospital (6) · Theratechnologies (6) · University of California, San Diego (1) · University of Washington (1) · Hudson Biotech (1) · Johns Hopkins University (1) · Columbia University (1) · National Institute of Nursing Research (NINR) (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test tesamorelin.

Studies

Open first, then newest update. How each study uses tesamorelin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call tesamorelin · ClinicalTrials.gg INT004590

  • MeSH (NLM) C479538tesamorelinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) MQG94M5EEOTESAMORELINConfirmed FDA, NLM
  • RxNorm 1044584One source FDA
  • NCI Thesaurus C77425TesamorelinOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.